Global Memantine Hydrochloride API Market Growth 2025-2031

Publication ID:

LPI08255709

Publication Date:

August 8, 2025

Pages:

134

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Memantine Hydrochloride API market size is predicted to grow from US$ 653 million in 2025 to US$ 859 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Memantine Hydrochloride API is the active pharmaceutical ingredient in the form of a hydrochloride salt of memantine. Memantine is a low - to - moderate - affinity, uncompetitive N - methyl - D - aspartate (NMDA) receptor antagonist. The API, Memantine Hydrochloride, is a white to off - white crystalline powder that is highly pure and meets strict quality standards. It is used in the manufacturing of various pharmaceutical formulations, primarily for the treatment of moderate to severe Alzheimer's disease. By blocking the NMDA receptor, it helps to regulate the excessive influx of calcium ions into neurons, which is believed to be involved in the pathophysiology of Alzheimer's disease, thereby potentially improving cognitive function and delaying the progression of the disease.
The global Memantine Hydrochloride API market is anticipated to experience notable growth in the coming years. This growth is mainly driven by the increasing prevalence of Alzheimer's disease and other neurodegenerative disorders, along with the growing aging population globally. As more people suffer from these diseases, the demand for effective treatments like Memantine Hydrochloride will continue to rise. Moreover, the development of generic drugs has also played a role in promoting market growth. With the entry of generic formulations, the market competition has become more intense, which not only helps to reduce costs and make the drug more affordable but also expands the application scope of Memantine Hydrochloride API. In addition, ongoing research into new therapeutic applications for NMDA receptor antagonists may further expand the market demand. However, the industry also faces some challenges. It is subject to strict market regulation, which requires manufacturers to comply with high - standard quality and safety requirements. The high cost of research and development and the expiration of drug patents also pose challenges to the profitability of enterprises. In a word, although the Memantine Hydrochloride API industry is faced with some challenges, the overall development trend is positive, and there is huge potential for growth in the future.
The 鈥淢emantine Hydrochloride API Industry Forecast鈥� looks at past sales and reviews total world Memantine Hydrochloride API sales in 2024, providing a comprehensive analysis by region and market sector of projected Memantine Hydrochloride API sales for 2025 through 2031. With Memantine Hydrochloride API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Memantine Hydrochloride API industry.
This Insight Report provides a comprehensive analysis of the global Memantine Hydrochloride API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Memantine Hydrochloride API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Memantine Hydrochloride API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Memantine Hydrochloride API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Memantine Hydrochloride API.
This report presents a comprehensive overview, market shares, and growth opportunities of Memantine Hydrochloride API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
笔耻谤颈迟测鈮�99%
Purity<99%
Segmentation by Application:
Capsule
Tablet
Oral Solution
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Dr. Reddy's Laboratories
Olpha
Taj Pharmaceuticals Limited
Anhui Puly Pharm
PROCOS SPA
Hikal
Alembic Pharmaceutical
Olon SpA
Alfa Chemistry
Sharon Bio-medicine Limited
Assia Chemical Industries Ltd
Anant Pharmaceuticals
Conscientia Industrial Co Ltd
Manus Aktteva Biopharma LLP
Unichem Laboratories Ltd
LGC Limited
Key Questions Addressed in this Report
What is the 10-year outlook for the global Memantine Hydrochloride API market?
What factors are driving Memantine Hydrochloride API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Memantine Hydrochloride API market opportunities vary by end market size?
How does Memantine Hydrochloride API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Memantine Hydrochloride API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Memantine Hydrochloride API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Memantine Hydrochloride API by Country/Region, 2020, 2024 & 2031
2.2 Memantine Hydrochloride API Segment by Type
2.2.1 笔耻谤颈迟测鈮�99%
2.2.2 Purity<99%
2.3 Memantine Hydrochloride API Sales by Type
2.3.1 Global Memantine Hydrochloride API Sales Market Share by Type (2020-2025)
2.3.2 Global Memantine Hydrochloride API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Memantine Hydrochloride API Sale Price by Type (2020-2025)
2.4 Memantine Hydrochloride API Segment by Application
2.4.1 Capsule
2.4.2 Tablet
2.4.3 Oral Solution
2.5 Memantine Hydrochloride API Sales by Application
2.5.1 Global Memantine Hydrochloride API Sale Market Share by Application (2020-2025)
2.5.2 Global Memantine Hydrochloride API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Memantine Hydrochloride API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Memantine Hydrochloride API Breakdown Data by Company
3.1.1 Global Memantine Hydrochloride API Annual Sales by Company (2020-2025)
3.1.2 Global Memantine Hydrochloride API Sales Market Share by Company (2020-2025)
3.2 Global Memantine Hydrochloride API Annual Revenue by Company (2020-2025)
3.2.1 Global Memantine Hydrochloride API Revenue by Company (2020-2025)
3.2.2 Global Memantine Hydrochloride API Revenue Market Share by Company (2020-2025)
3.3 Global Memantine Hydrochloride API Sale Price by Company
3.4 Key Manufacturers Memantine Hydrochloride API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Memantine Hydrochloride API Product Location Distribution
3.4.2 Players Memantine Hydrochloride API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Memantine Hydrochloride API by Geographic Region
4.1 World Historic Memantine Hydrochloride API Market Size by Geographic Region (2020-2025)
4.1.1 Global Memantine Hydrochloride API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Memantine Hydrochloride API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Memantine Hydrochloride API Market Size by Country/Region (2020-2025)
4.2.1 Global Memantine Hydrochloride API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Memantine Hydrochloride API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Memantine Hydrochloride API Sales Growth
4.4 APAC Memantine Hydrochloride API Sales Growth
4.5 Europe Memantine Hydrochloride API Sales Growth
4.6 Middle East & Africa Memantine Hydrochloride API Sales Growth
5 Americas
5.1 Americas Memantine Hydrochloride API Sales by Country
5.1.1 Americas Memantine Hydrochloride API Sales by Country (2020-2025)
5.1.2 Americas Memantine Hydrochloride API Revenue by Country (2020-2025)
5.2 Americas Memantine Hydrochloride API Sales by Type (2020-2025)
5.3 Americas Memantine Hydrochloride API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Memantine Hydrochloride API Sales by Region
6.1.1 APAC Memantine Hydrochloride API Sales by Region (2020-2025)
6.1.2 APAC Memantine Hydrochloride API Revenue by Region (2020-2025)
6.2 APAC Memantine Hydrochloride API Sales by Type (2020-2025)
6.3 APAC Memantine Hydrochloride API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Memantine Hydrochloride API by Country
7.1.1 Europe Memantine Hydrochloride API Sales by Country (2020-2025)
7.1.2 Europe Memantine Hydrochloride API Revenue by Country (2020-2025)
7.2 Europe Memantine Hydrochloride API Sales by Type (2020-2025)
7.3 Europe Memantine Hydrochloride API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Memantine Hydrochloride API by Country
8.1.1 Middle East & Africa Memantine Hydrochloride API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Memantine Hydrochloride API Revenue by Country (2020-2025)
8.2 Middle East & Africa Memantine Hydrochloride API Sales by Type (2020-2025)
8.3 Middle East & Africa Memantine Hydrochloride API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Memantine Hydrochloride API
10.3 Manufacturing Process Analysis of Memantine Hydrochloride API
10.4 Industry Chain Structure of Memantine Hydrochloride API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Memantine Hydrochloride API Distributors
11.3 Memantine Hydrochloride API Customer
12 World Forecast Review for Memantine Hydrochloride API by Geographic Region
12.1 Global Memantine Hydrochloride API Market Size Forecast by Region
12.1.1 Global Memantine Hydrochloride API Forecast by Region (2026-2031)
12.1.2 Global Memantine Hydrochloride API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Memantine Hydrochloride API Forecast by Type (2026-2031)
12.7 Global Memantine Hydrochloride API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Dr. Reddy's Laboratories
13.1.1 Dr. Reddy's Laboratories Company Information
13.1.2 Dr. Reddy's Laboratories Memantine Hydrochloride API Product Portfolios and Specifications
13.1.3 Dr. Reddy's Laboratories Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Dr. Reddy's Laboratories Main Business Overview
13.1.5 Dr. Reddy's Laboratories Latest Developments
13.2 Olpha
13.2.1 Olpha Company Information
13.2.2 Olpha Memantine Hydrochloride API Product Portfolios and Specifications
13.2.3 Olpha Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Olpha Main Business Overview
13.2.5 Olpha Latest Developments
13.3 Taj Pharmaceuticals Limited
13.3.1 Taj Pharmaceuticals Limited Company Information
13.3.2 Taj Pharmaceuticals Limited Memantine Hydrochloride API Product Portfolios and Specifications
13.3.3 Taj Pharmaceuticals Limited Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Taj Pharmaceuticals Limited Main Business Overview
13.3.5 Taj Pharmaceuticals Limited Latest Developments
13.4 Anhui Puly Pharm
13.4.1 Anhui Puly Pharm Company Information
13.4.2 Anhui Puly Pharm Memantine Hydrochloride API Product Portfolios and Specifications
13.4.3 Anhui Puly Pharm Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Anhui Puly Pharm Main Business Overview
13.4.5 Anhui Puly Pharm Latest Developments
13.5 PROCOS SPA
13.5.1 PROCOS SPA Company Information
13.5.2 PROCOS SPA Memantine Hydrochloride API Product Portfolios and Specifications
13.5.3 PROCOS SPA Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 PROCOS SPA Main Business Overview
13.5.5 PROCOS SPA Latest Developments
13.6 Hikal
13.6.1 Hikal Company Information
13.6.2 Hikal Memantine Hydrochloride API Product Portfolios and Specifications
13.6.3 Hikal Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hikal Main Business Overview
13.6.5 Hikal Latest Developments
13.7 Alembic Pharmaceutical
13.7.1 Alembic Pharmaceutical Company Information
13.7.2 Alembic Pharmaceutical Memantine Hydrochloride API Product Portfolios and Specifications
13.7.3 Alembic Pharmaceutical Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Alembic Pharmaceutical Main Business Overview
13.7.5 Alembic Pharmaceutical Latest Developments
13.8 Olon SpA
13.8.1 Olon SpA Company Information
13.8.2 Olon SpA Memantine Hydrochloride API Product Portfolios and Specifications
13.8.3 Olon SpA Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Olon SpA Main Business Overview
13.8.5 Olon SpA Latest Developments
13.9 Alfa Chemistry
13.9.1 Alfa Chemistry Company Information
13.9.2 Alfa Chemistry Memantine Hydrochloride API Product Portfolios and Specifications
13.9.3 Alfa Chemistry Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Alfa Chemistry Main Business Overview
13.9.5 Alfa Chemistry Latest Developments
13.10 Sharon Bio-medicine Limited
13.10.1 Sharon Bio-medicine Limited Company Information
13.10.2 Sharon Bio-medicine Limited Memantine Hydrochloride API Product Portfolios and Specifications
13.10.3 Sharon Bio-medicine Limited Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sharon Bio-medicine Limited Main Business Overview
13.10.5 Sharon Bio-medicine Limited Latest Developments
13.11 Assia Chemical Industries Ltd
13.11.1 Assia Chemical Industries Ltd Company Information
13.11.2 Assia Chemical Industries Ltd Memantine Hydrochloride API Product Portfolios and Specifications
13.11.3 Assia Chemical Industries Ltd Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Assia Chemical Industries Ltd Main Business Overview
13.11.5 Assia Chemical Industries Ltd Latest Developments
13.12 Anant Pharmaceuticals
13.12.1 Anant Pharmaceuticals Company Information
13.12.2 Anant Pharmaceuticals Memantine Hydrochloride API Product Portfolios and Specifications
13.12.3 Anant Pharmaceuticals Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Anant Pharmaceuticals Main Business Overview
13.12.5 Anant Pharmaceuticals Latest Developments
13.13 Conscientia Industrial Co Ltd
13.13.1 Conscientia Industrial Co Ltd Company Information
13.13.2 Conscientia Industrial Co Ltd Memantine Hydrochloride API Product Portfolios and Specifications
13.13.3 Conscientia Industrial Co Ltd Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Conscientia Industrial Co Ltd Main Business Overview
13.13.5 Conscientia Industrial Co Ltd Latest Developments
13.14 Manus Aktteva Biopharma LLP
13.14.1 Manus Aktteva Biopharma LLP Company Information
13.14.2 Manus Aktteva Biopharma LLP Memantine Hydrochloride API Product Portfolios and Specifications
13.14.3 Manus Aktteva Biopharma LLP Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Manus Aktteva Biopharma LLP Main Business Overview
13.14.5 Manus Aktteva Biopharma LLP Latest Developments
13.15 Unichem Laboratories Ltd
13.15.1 Unichem Laboratories Ltd Company Information
13.15.2 Unichem Laboratories Ltd Memantine Hydrochloride API Product Portfolios and Specifications
13.15.3 Unichem Laboratories Ltd Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Unichem Laboratories Ltd Main Business Overview
13.15.5 Unichem Laboratories Ltd Latest Developments
13.16 LGC Limited
13.16.1 LGC Limited Company Information
13.16.2 LGC Limited Memantine Hydrochloride API Product Portfolios and Specifications
13.16.3 LGC Limited Memantine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 LGC Limited Main Business Overview
13.16.5 LGC Limited Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂